1,110
Participants
Start Date
April 24, 2013
Primary Completion Date
October 31, 2021
Study Completion Date
October 31, 2021
Low dose nadroparin
"Fixed low dose nadroparin:~* \< 100 kg: 2850 IU subcutaneously once-daily~* 100 kg and above: 3800 IU subcutaneously once-daily"
Intermediate dose nadroparin
"Intermediate weight-adjusted dose nadroparin:~* \< 50 kg: 3800 IU subcutaneously once-daily;~* 50 to \< 70 kg: 5700 IU subcutaneously once-daily;~* 70 to \< 100 kg: 7600 IU subcutaneously once-daily;~* 100 kg or above: 9500 IU subcutaneously once-daily."
Low dose enoxaparin
"Fixed low dose enoxaparin:~* \< 100 kg: 40 mg subcutaneously once-daily~* 100 kg and above: 60 mg subcutaneously once-daily"
Intermediate dose enoxaparin
"Intermediate weight-adjusted dose enoxaparin:~* \< 50 kg: 60 mg subcutaneously once-daily, or;~* 50 kg to \< 70 kg: 80 mg subcutaneously once-daily, or;~* 70 kg to \< 100 kg: 100 mg subcutaneously once-daily, or;~* 100 kg or above: 120 mg subcutaneously once-daily."
Low dose dalteparin
"Fixed low dose dalteparin:~* \< 100 kg: 5000 IU subcutaneously once-daily~* 100 kg and above: 7500 IU subcutaneously once-daily"
Intermediate dose dalteparin
"Intermediate weight-adjusted dose dalteparin:~* \< 50 kg: 7500 IU subcutaneously once-daily, or;~* 50 kg to \< 70 kg: 10000 IU subcutaneously once-daily, or;~* 70 kg to \< 100 kg: 12500 IU subcutaneously once-daily, or;~* 100 kg or above: 15000 IU subcutaneously once-daily."
Fixed low dose tinzaparin
"Fixed low dose tinzaparin:~* \< 100 kg: 3500 IU subcutaneously once-daily~* 100 kg and above: 4500 IU subcutaneously once-daily"
Intermediate dose tinzaparin
"Intermediate weight-adjusted dose tinzaparin:~* \< 50 kg: 4500 IU subcutaneously once-daily, or;~* 50 kg to \< 70 kg: 7000 IU subcutaneously once-daily, or;~* 70 kg to \< 100 kg: 10000 IU subcutaneously once-daily, or;~* 100 kg or above: 12000 IU subcutaneously once-daily."
"Weill Cornell Medicine , NewYork-Presbyterian"
KU Leuven, Leuven
The Ottawa Hospital, Ottawa
Aalborg University Hospital, Aalborg
Aarhus University Hospital, Aarhus
CHU de Besancon, Besançon
CHU de Bordeaux, Bordeaux
CHU de Brest, Brest
CHU de Caen, Caen
CHU de Clermont - Ferrand, Clermont-Ferrand
APHP Louis Mourier, Colombes
CHU de Grenoble, Grenoble
CHU de Limoges, Limoges
Hopiteaux de Marseille, Marseille
Marseille St Joseph, Marseille
CHU de Nancy, Nancy
CHU de Nice, Nice
CHU de Nîmes, Nîmes
APHP Antoine Béclère, Paris
APHP Port Royal, Paris
CHU de Poitiers, Paris
Centra Hospitalier de Roanne, Roanne
La Réunion - Saint-Denis, Saint-Denis
Hopital Nord, CHU de Saint Etienne, Saint-Etienne
La Réunion deSt Pierre, Saint-Pierre
Polyclinique de Sète, Sète
CHIC de Toulon, Toulon
CHU de Tours, Tours
Corke University Hospital, Cork
Coombe Women's Hospital, Dublin
Rotunda Hospital, Dublin
The National Maternity Hospital, Dublin
Letterkenny University Hospital, Letterkenny
University Hospital Limerick, Limerick
Jeroen Bosch Ziekenhuis, 's-Hertogenbosch
Flevoziekenhuis, Almere Stad
OLVG oost, Amsterdam
SLAZ, Amsterdam
VU medical center, Amsterdam
Gelre Ziekenhuizen, Apeldoorn
Rijnstate hospital, Arnhem
Wilhelmina Ziekenhuis, Assen
Rode Kruis Ziekenhuis, Beverwijk
Amphia ziekenhuis, Breda
Reinier de Graaf Groep, Delft
Deventer Ziekenhuis, Deventer
Slingeland, Doetinchem
Albert Schweitzer, Dordrecht
Gelderse Vallei, Ede
Admiraal de Ruijter Ziekenhuis, Goes
Groene Hart Ziekenhuis, Gouda
Martini Ziekenhuis, Groningen
UMCG, Groningen
Spaarne Gasthuis, Haarlem
St Jansdal, Harderwijk
Atrium MC, Heerlen
MC Leeuwarden, Leeuwarden
LUMC, Leiden
MUMC, Maastricht
Canisius-Wilhelmina Ziekenhuis, Nijmegen
St. Radboud UMC, Nijmegen
Erasmus MC, Rotterdam
Bronovo ziekenhuis, The Hague
HAGA ziekenhuis, The Hague
TweeSteden, Tilburg
Diakonessen Utrecht, Utrecht
UMCU, Utrecht
Máxima MC, Veldhoven
Oslo University Hospital, Oslo
"Federal State Institution Research Center for Obstetrics, Gynecology and Perinatology", Moscow
Vall d'Hebron Hospital, Barcelona
Academic Medical Center, Amsterdam
Collaborators (1)
Netherlands Organisation for Scientific Research
OTHER_GOV
Aspen Pharma
UNKNOWN
CHU of Saint Etienne: French Ministry of Health Grant (sponsor of the French part of the study)
UNKNOWN
Rotunda Hospital: Definitive Interventions and Feasibility Awards (DIFA) 2017 (sponsor of the Irish part of the study))
UNKNOWN
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER